PMID- 29388365 OWN - NLM STAT- MEDLINE DCOM- 20190429 LR - 20190429 IS - 2050-4527 (Electronic) IS - 2050-4527 (Linking) VI - 6 IP - 2 DP - 2018 Jun TI - Collagen-derived peptides modulate CD4(+) T-cell differentiation and suppress allergic responses in mice. PG - 245-255 LID - 10.1002/iid3.213 [doi] AB - INTRODUCTION: Collagen peptides have been widely used as a food supplement. After ingestion of collagen peptides, oligopeptides containing hydroxyproline (Hyp), which are known to have some physiological activities, are detected in peripheral blood. However, the effects of collagen-peptide administration on immune response are unclear. In the present study, we tested the effects of collagen-peptide ingestion on allergic response and the effects of collagen-derived oligopeptides on CD4(+) T-cell differentiation. METHODS: BALB/c mice fed a collagen-peptide diet were immunized with ovalbumin (OVA), and their serum IgE and IgG levels, active cutaneous anaphylaxis, and cytokine secretion by splenocytes were examined. Naive CD4(+) T cells were stimulated with anti-CD3 and anti-CD28 in the presence of collagen-derived oligopeptides, and the expression of IFN-gamma, IL-4, and Foxp3 was analyzed. RESULTS: In an active anaphylaxis model, oral administration of collagen peptides suppressed serum OVA-specific immunoglobulin E (IgE) production and diminished anaphylaxis responses. In this model, the ingestion of collagen peptides skewed the pattern of cytokine production by splenocytes toward T-helper (Th) type 1 and regulatory T (Treg) cells. In vitro T-helper cell differentiation assays showed that Hyp-containing oligopeptides promoted Th1 differentiation by upregulating IFN-gamma-induced signal transducer and activator of transcription 1 (STAT1) signaling. These oligopeptides also promoted the development of Foxp3(+) Treg cells in response to antigen stimulation in the presence of TGF-beta. CONCLUSIONS: Collagen-peptide ingestion suppresses allergic responses by skewing the balance of CD4(+) T cells toward Th1 and Treg cells and seems to be a promising agent for preventing allergies and inflammatory diseases. CI - (c) 2018 The Authors. Immunity, Inflammation and Disease Published by John Wiley & Sons Ltd. FAU - Nishikimi, Akihiko AU - Nishikimi A AUID- ORCID: 0000-0001-9497-7557 AD - Department of Biosciences, School of Science, Kitasato University, Sagamihara, Kanagawa, Japan. FAU - Koyama, Yoh-Ichi AU - Koyama YI AD - Research Institute of Biomatrix, Nippi Inc., Toride, Ibaraki, Japan. AD - Institute for Animal Reproduction, Kasumigaura, Ibaraki, Japan. FAU - Ishihara, Sayaka AU - Ishihara S AD - Department of Biosciences, School of Science, Kitasato University, Sagamihara, Kanagawa, Japan. FAU - Kobayashi, Shusaku AU - Kobayashi S AD - Department of Biosciences, School of Science, Kitasato University, Sagamihara, Kanagawa, Japan. FAU - Tometsuka, Chisa AU - Tometsuka C AD - Research Institute of Biomatrix, Nippi Inc., Toride, Ibaraki, Japan. FAU - Kusubata, Masashi AU - Kusubata M AD - Research Institute of Biomatrix, Nippi Inc., Toride, Ibaraki, Japan. FAU - Kuwaba, Kumiko AU - Kuwaba K AD - Research Institute of Biomatrix, Nippi Inc., Toride, Ibaraki, Japan. FAU - Hayashida, Osamu AU - Hayashida O AD - Research Institute of Biomatrix, Nippi Inc., Toride, Ibaraki, Japan. FAU - Hattori, Shunji AU - Hattori S AD - Research Institute of Biomatrix, Nippi Inc., Toride, Ibaraki, Japan. FAU - Katagiri, Koko AU - Katagiri K AD - Department of Biosciences, School of Science, Kitasato University, Sagamihara, Kanagawa, Japan. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20180201 PL - England TA - Immun Inflamm Dis JT - Immunity, inflammation and disease JID - 101635460 RN - 0 (Peptides) RN - 37341-29-0 (Immunoglobulin E) RN - 9006-59-1 (Ovalbumin) RN - 9007-34-5 (Collagen) SB - IM MH - Administration, Oral MH - Anaphylaxis/blood/diet therapy/immunology/*prevention & control MH - Animals MH - Cell Differentiation/drug effects/immunology MH - Collagen/*administration & dosage/immunology MH - *Dietary Supplements MH - Disease Models, Animal MH - Humans MH - Immunoglobulin E/blood/immunology MH - Lymphocyte Activation/drug effects/immunology MH - Mice MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Ovalbumin/immunology MH - Peptides/administration & dosage/immunology MH - T-Lymphocytes, Regulatory/*drug effects/immunology MH - Th1 Cells/*drug effects/immunology PMC - PMC5946155 OTO - NOTNLM OT - Active cutaneous anaphylaxis model OT - T cells OT - collagen peptide EDAT- 2018/02/02 06:00 MHDA- 2019/04/30 06:00 PMCR- 2018/02/01 CRDT- 2018/02/02 06:00 PHST- 2017/10/10 00:00 [received] PHST- 2017/12/04 00:00 [revised] PHST- 2017/12/09 00:00 [accepted] PHST- 2018/02/02 06:00 [pubmed] PHST- 2019/04/30 06:00 [medline] PHST- 2018/02/02 06:00 [entrez] PHST- 2018/02/01 00:00 [pmc-release] AID - IID3213 [pii] AID - 10.1002/iid3.213 [doi] PST - ppublish SO - Immun Inflamm Dis. 2018 Jun;6(2):245-255. doi: 10.1002/iid3.213. Epub 2018 Feb 1.